Faculty profile

Danica Stanimirovic

ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Danica Stanimirovic

Researcher

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2013.
Supervisor on 1 trainee award (1 CIHR), most recently in 2009.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Amyloid Beta Blood-Brain Barrier Imaging Inflammation Transporters Vascular Dementia

Latest papers

Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.
Antimicrobial agents and chemotherapy · 2026 · senior author
In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.
Fluids and barriers of the CNS · 2025 · senior author
A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024 · senior author

All 30 publications

Latest funding

Novel Approaches Directed to Prevention and Treatment of Huntington Disease
CIHR · 2016 · Co-investigator
$3,568,457
Mechanisms of amyloid-beta clearance in models of vascular cognitive impairment and mixed dementia
CIHR · 2013 · Nominated PI
$240,724
The Role of Bone Morphogenetic Protein-7 in Cortical Neurogenesis
CIHR · 2009 · Supervisor
$17,500

All 3 grants and awards

30 publications.

Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.

Sulea T, Stuible M, Moreno M, Pelletier A, Rossotti MA, Cepero-Donates Y, Slinn J, Salois P, Tran A, Hewitt M, Yogi A, Rohani N, Cass B, Lenferink AEG, Tanha J, Ling B, Lessard E, Delafosse L, Sandhu JK, Stanimirovic D

Antimicrobial agents and chemotherapy2026Senior author

DOI: 10.1128/aac.00024-26 PMID: 41870123

In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.

Costain WJ, Haqqani AS, Hussack G, van Faassen H, Lessard E, Ling B, Brunette E, Ly D, Fang H, Bultinck J, Geysens S, Pynaert G, Piens K, Ryckaert S, Fudalej F, Vervecken W, Stanimirovic D

Fluids and barriers of the CNS2025Senior author

DOI: 10.1186/s12987-024-00617-6 PMID: 39810248

A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.

Martina M, Banderali U, Yogi A, Arbabi Ghahroudi M, Liu H, Sulea T, Durocher Y, Hussack G, van Faassen H, Chakravarty B, Liu QY, Iqbal U, Ling B, Lessard E, Sheff J, Robotham A, Callaghan D, Moreno M, Comas T, Ly D, Stanimirovic D

Advanced science (Weinheim, Baden-Wurttemberg, Germany)2024Senior author

DOI: 10.1002/advs.202405432 PMID: 39206821

Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease.

Caron NS, Aly AE, Findlay Black H, Martin DDO, Schmidt ME, Ko S, Anderson C, Harvey EM, Casal LL, Anderson LM, Rahavi SMR, Reid GSD, Oda MN, Stanimirovic D, Abulrob A, McBride JL, Leavitt BR, Hayden MR

Journal of controlled release : official journal of the Controlled Release Society2024

DOI: 10.1016/j.jconrel.2024.01.011 PMID: 38215984

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.

Caron NS, Haqqani AS, Sandhu A, Aly AE, Findlay Black H, Bone JN, McBride JL, Abulrob A, Stanimirovic D, Leavitt BR, Hayden MR

Brain communications2022

DOI: 10.1093/braincomms/fcac309 PMID: 36523269

Pharmacokinetics and Pharmacodynamic Effect of a Blood-Brain Barrier-Crossing Fusion Protein Therapeutic for Alzheimer's Disease in Rat and Dog.

Lessard E, Rennie K, Haqqani A, Ling B, Whitfield J, Paradis A, Araujo J, Yoganathan N, Gillard J, Stanimirovic D, Chakravarthy B

Pharmaceutical research2022

DOI: 10.1007/s11095-022-03285-z PMID: 35704250

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.

Kang MS, Shin M, Ottoy J, Aliaga AA, Mathotaarachchi S, Quispialaya K, Pascoal TA, Collins DL, Chakravarty MM, Mathieu A, Sandelius Å, Blennow K, Zetterberg H, Massarweh G, Soucy JP, Cuello AC, Gauthier S, Waterston M, Yoganathan N, Lessard E, Haqqani A, Rennie K, Stanimirovic D, Chakravarthy B, Rosa-Neto P

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

DOI: 10.1177/0271678x211035625 PMID: 34378436

Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.

Singh R, Moreno M, Stanimirovic D

European journal of drug metabolism and pharmacokinetics2021Senior author

DOI: 10.1007/s13318-021-00691-3 PMID: 34120326

Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor.

Sheff J, Wang P, Xu P, Arbour M, Masson L, van Faassen H, Hussack G, Kemmerich K, Brunette E, Stanimirovic D, Hill JJ, Kelly J, Ni F

Scientific reports2021

DOI: 10.1038/s41598-021-83198-w PMID: 33608571

Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases.

Bélanger K, Iqbal U, Tanha J, MacKenzie R, Moreno M, Stanimirovic D

Antibodies (Basel, Switzerland)2019Senior author

DOI: 10.3390/antib8020027 PMID: 31544833

Something wrong or missing on this profile? Suggest a correction

Danica Stanimirovic

Research

Latest papers

Latest funding

Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection.

In vivo brain delivery of BBB-enabled iduronate 2-sulfatase in rats.

A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models.

Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease.

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity.

Pharmacokinetics and Pharmacodynamic Effect of a Blood-Brain Barrier-Crossing Fusion Protein Therapeutic for Alzheimer's Disease in Rat and Dog.

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.

Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human.

Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor.

Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases.

Novel Approaches Directed to Prevention and Treatment of Huntington Disease

Mechanisms of amyloid-beta clearance in models of vascular cognitive impairment and mixed dementia

The Role of Bone Morphogenetic Protein-7 in Cortical Neurogenesis

Frequent collaborators

Abedelnasser Abulrob

Wandong Zhang

Marzia Martina

Serge Gauthier

Jean-Paul Soucy

Pedro Rosa-Neto

Qing Liu

Serge Gauthier